Indap

Indapamide, the active ingredient in Indap, is a thiazide‑like diuretic presented as a 1.5 mg oral tablet for oral use. It treats hypertension and edema in adult patients.\n\nGNH India supplies Indap as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indapamide is used to manage conditions related to fluid retention and elevated blood pressure.\n\nHypertension: lowers systolic and diastolic pressure to reduce cardiovascular risk.\nEdema: promotes diuresis to decrease excess fluid in peripheral tissues.\nCongestive heart failure: helps control fluid overload and improve symptom control.

Indapamide may cause a range of adverse reactions, from mild to serious.\n\nCommon Side Effects:\n- Dizziness or light‑headedness\n- Headache\n- Increased urinary frequency\n- Electrolyte disturbances, especially low potassium\n- Fatigue\n- Nausea\n\nSerious or Rare Side Effects:\n- Severe dehydration or electrolyte imbalance\n- Hyponatremia or hyperuricemia leading to gout attacks\n- Allergic reactions such as rash or angioedema\n- Blood dyscrasias including leukopenia or thrombocytopenia

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications.\n\nMonitor electrolytes: check serum potassium and sodium regularly.\nAssess renal function: evaluate creatinine clearance prior to use.\nUse caution in diabetes: monitor blood glucose as diuresis may affect glycemic control.\nAvoid in severe liver disease: impaired metabolism can increase toxicity.\nAdjust dose in the elderly: start with the lowest effective dose.\nStore at room temperature: keep in the original pack, protect from moisture.

Indapamide can alter the pharmacokinetics or pharmacodynamics of several medicines; awareness of these interactions helps prevent adverse outcomes.\n\nMajor Interactions (Avoid):\n- Lithium: increased lithium levels may cause toxicity.\n- NSAIDs: may reduce diuretic efficacy and impair renal function.\n- ACE inhibitors or ARBs: combined use can lead to excessive hypotension or renal impairment.\n\nModerate Interactions (Monitor Closely):\n- Digoxin: risk of arrhythmia due to electrolyte shifts.\n- Antidiabetic agents: may enhance hypoglycemic effect.\n- Warfarin: potential alteration of INR values.